Author Index

Search or browse for an author across our entire electronic archive

Search results for: N
Results 121 - 130 of 801 shown below

  • Nakamoto, S

    N Miura, N Onuki, A Rathi, A Virmani, S Nakamoto, Y Kishimoto, Y Murawaki, H Kawasaki, J Hasegawa, M Oshimura, W D Travis and A F Gazdar

    hTR repressor-related gene on human chromosome 10p15.1

    doi:10.1054/bjoc.2001.2121

  • Nakamoto, Y

    Y Nakamoto, H Sakahara, T Saga, N Sato, S Zhao, Y Arano, Y Fujioka, H Saji and J Konishi

    A novel immunoscintigraphy technique using metabolizable linker with angiotensin II treatment

    doi:10.1038/sj.bjc.6690286

  • Nakamura, H

    M Otake, M Nishiwaki, Y Kobayashi, S Baba, E Kohno, T Kawasaki, Y Fujise and H Nakamura

    Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma

    doi:10.1038/sj.bjc.6601135

  • H Nakamura, N Kawasaki, M Taguchi and K Kabasawa

    Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis

    advance online publication, 2005-03-08 00:00:00.000;

    doi:10.1038/sj.bjc.6602414

  • J Kurebayashi, T Otsuki, M Kurosumi, S Yamamoto, K Tanaka, M Mochizuki and H Nakamura

    Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6

    doi:10.1038/sj.bjc.6690114

  • M Sumitomo, M Tachibana, M Murai, M Hayakawa, H Nakamura, A Takayanagi and N Shimizu

    Overexpression of IL-1ra gene up-regulates interleukin-1beta converting enzyme (ICE) gene expression: possible mechanism underlying IL-1beta-resistance of cancer cells

    doi:10.1038/sj.bjc.6690688

  • K Komatsu, Y Kobune-Fujiwara, A Andoh, S Ishiguro, H Hunai, N Suzuki, M Kameyama, K Murata, J Miyoshi, H Akedo, M Tatsuta and H Nakamura

    Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma

    doi:10.1054/bjoc.2000.1356

  • Nakamura, I

    T Hamaguchi, Y Matsumura, M Suzuki, K Shimizu, R Goda, I Nakamura, I Nakatomi, M Yokoyama, K Kataoka and T Kakizoe

    NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel

    advance online publication, 2005-03-22 00:00:00.000;

    doi:10.1038/sj.bjc.6602479

  • Nakamura, J

    E Mochiki, T Ohno, Y Kamiyama, R Aihara, N Haga, H Ojima, J Nakamura, H Ohsawa, T Nakabayashi, K Takeuchi, T Asao and H Kuwano

    Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer

    advance online publication, 2006-11-28 00:00:00.000;

    doi:10.1038/sj.bjc.6603497

  • Nakamura, K

    T Asano, K Nakamura, H Fujii, N Horichi, T Ohmori, K Hasegawa, T Isoe, M Adachi, N Otake and Y Fukunaga

    Altered expression of topoisomerase IIalpha contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylation

    advance online publication, 2005-03-29 00:00:00.000;

    doi:10.1038/sj.bjc.6602498

  • K Nakamura, T Yamaguchi, T Ishihara, A Kobayashi, H Tadenuma, K Sudo, H Kato and H Saisho

    Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer

    advance online publication, 2005-06-07 00:00:00.000;

    doi:10.1038/sj.bjc.6602644

  • K Nakamura, T Yamaguchi, T Ishihara, K Sudo, H Kato and H Saisho

    Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer

    advance online publication, 2006-05-23 00:00:00.000;

    doi:10.1038/sj.bjc.6603168

  • Y Nakano, S Tanno, K Koizumi, T Nishikawa, K Nakamura, M Minoguchi, T Izawa, Y Mizukami, T Okumura and Y Kohgo

    Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells

    advance online publication, 2007-01-16 00:00:00.000;

    doi:10.1038/sj.bjc.6603559

  • M Yashiro, O Shinto, K Nakamura, M Tendo, T Matsuoka, T Matsuzaki, R Kaizaki, M Ohira, A Miwa and K Hirakawa

    Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model

    doi:10.1038/sj.bjc.6605296

  • Nakamura, M

    N Konishi, K Tsujikawa, H Yamamoto, E Ishida, M Nakamura, K Shimada, K Yane, H Yamashita and S Noguchi

    Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas

    doi:10.1038/sj.bjc.3390-02mp

  • N Konishi, K Tsujikawa, H Yamamoto, E Ishida, M Nakamura, K Shimada, K Yane, H Yamashita and S Noguchi

    Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas

    doi:10.1038/sj.bjc.6600876

  • H Ota, H Nagano, M Sakon, H Eguchi, M Kondo, T Yamamoto, M Nakamura, B Damdinsuren, H Wada, S Marubashi, A Miyamoto, K Dono, K Umeshita, S Nakamori, K Wakasa and M Monden

    Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression

    advance online publication, 2005-08-16 00:00:00.000;

    doi:10.1038/sj.bjc.6602742

  • S Matsuyoshi, K Shimada, M Nakamura, E Ishida and N Konishi

    FADD phosphorylation is critical for cell cycle regulation in breast cancer cells

    advance online publication, 2006-01-31 00:00:00.000;

    doi:10.1038/sj.bjc.6602955

  • T Tokunaga, M Nakamura, Y Oshika, Y Abe, Y Ozeki, Y Fukushima, H Hatanaka, S Sadahiro, H Kijima, T Tsuchida, H Yamazaki, N Tamaoki and Y Ueyama

    Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer

    doi:10.1038/sj.bjc.6690056

  • Y Ito, M Monden, T Takeda, H Eguchi, K Umeshita, H Nagano, S Nakamori, K Dono, M Sakon, M Nakamura, M Tsujimoto, M Nakahara, K Nakao, Y Yokosaki and N Matsuura

    The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma

    doi:10.1054/bjoc.1999.1065

  • T Tokunaga, T Tsuchida, H Kijima, K Okamoto, Y Oshika, N Sawa, Y Ohnishi, H Yamazaki, S Miura, Y Ueyama and M Nakamura

    Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line

    doi:10.1054/bjoc.2000.1363

  • Nakamura, S

    S Ohwada, T Ikeya, T Yokomori, T Kusaba, T Roppongi, T Takahashi, S Nakamura, S Kakinuma, S Iwazaki, H Ishikawa, S Kawate, T Nakajima and Y Morishita

    Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study

    doi:10.1038/sj.bjc.6601619

  • S Takagi, R Inenaga, R Oya, S Nakamura and K Ikemura

    Blood vessel density correlates with the effects of targeted intra-arterial carboplatin infusion with concurrent radiotherapy for squamous cell carcinomas of the oral cavity and oropharynx

    advance online publication, 2006-05-02 00:00:00.000;

    doi:10.1038/sj.bjc.6603138

  • K Nouso, Y M Ito, K Kuwaki, Y Kobayashi, S Nakamura, Y Ohashi and K Yamamoto

    Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis

    advance online publication, 2008-03-18 00:00:00.000;

    doi:10.1038/sj.bjc.6604282

  • M Toi, H Iwata, Y Fujiwara, Y Ito, S Nakamura, Y Tokuda, T Taguchi, Y Rai, K Aogi, T Arai, J Watanabe, T Wakamatsu, K Katsura, C E Ellis, R C Gagnon, K E Allen, Y Sasaki and S Takashima

    Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies

    advance online publication, 2009-10-20 00:00:00.000;

    doi:10.1038/sj.bjc.6605343

  • T Ueno, M Toi, M Koike, S Nakamura and T Tominaga

    Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration

    doi:10.1054/bjoc.2000.1272

  • N Futamura, S Nakamura, M Tatematsu, Y Yamamura, R Kannagi and H Hirose

    Clinicopathologic significance of sialyl Le xexpression in advanced gastric carcinoma

    doi:10.1054/bjoc.2000.1484

  • Nakamura, T

    T Nakamura, A Scorilas, C Stephan, G M Yousef, G Kristiansen, K Jung and E P Diamandis

    Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues

    doi:10.1038/sj.bjc.6600869

  • E Canaani, T Nakamura, T Rozovskaia, S T Smith, T Mori, C M Croce and A Mazo

    ALL-1/MLL1, a homologue of Drosophila TRITHORAX, modifies chromatin and is directly involved in infant acute leukaemia

    doi:10.1038/sj.bjc.6601639

  • N Fuwa, T Kodaira, K Furutani, H Tachibana, T Nakamura, R Nakahara, T Tomoda, H Inokuchi and T Daimon

    Intra-arterial chemoradiotherapy for locally advanced oral cavity cancer: analysis of therapeutic results in134 cases

    advance online publication, 2008-02-19 00:00:00.000;

    doi:10.1038/sj.bjc.6604272

  • R Hasina, K Matsumoto, N Matsumoto-Taniura, I Kato, M Sakuda and T Nakamura

    Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line

    doi:10.1038/sj.bjc.6690587

  • N Matsumoto-Taniura, K Matsumoto and T Nakamura

    Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts

    doi:10.1038/sj.bjc.6690677

  • A Uchiyama, T Morisaki, K Beppu, M Kojima, Y Matsunari, A Nakatsuka, K Mizumoto, K Matsumoto, T Nakamura and M Tanaka

    Hepatocyte growth factor and invasion-stimulatory activity are induced in pleural fluid by surgery in lung cancer patients

    doi:10.1038/sj.bjc.6690754

  • H Yamamoto, T Nakayama, H Murakami, T Hosaka, T Nakamata, T Tsuboyama, M Oka, T Nakamura and J Toguchida

    High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients

    doi:10.1054/bjoc.2000.1213

  • N Maehara, K Matsumoto, K Kuba, K Mizumoto, M Tanaka and T Nakamura

    NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells

    doi:10.1054/bjoc.2000.1682

  • Nakamura, Y

    D G Duda, M Sunamura, L Lozonschi, T Yokoyama, T Yatsuoka, F Motoi, A Horii, K Tani, S Asano, Y Nakamura and S Matsuno

    Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis

    doi:10.1038/sj.bjc.6600067

  • S Ikematsu, A Nakagawara, Y Nakamura, S Sakuma, K Wakai, T Muramatsu and K Kadomatsu

    Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas

    doi:10.1038/sj.bjc.6600938

  • A Kinoshita, M Fukuda, H Soda, S Nagashima, M Fukuda, H Takatani, M Kuba, Y Nakamura, J Tsurutani, S Kohno and M Oka

    Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer

    advance online publication, 2006-04-04 00:00:00.000;

    doi:10.1038/sj.bjc.6603079

  • Y Nakamura, F Tanaka, N Haraguchi, K Mimori, T Matsumoto, H Inoue, K Yanaga and M Mori

    Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer

    advance online publication, 2007-07-24 00:00:00.000;

    doi:10.1038/sj.bjc.6603905

  • M Unoki, J D Kelly, D E Neal, B A J Ponder, Y Nakamura and R Hamamoto

    UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer

    advance online publication, 2009-06-02 00:00:00.000;

    doi:10.1038/sj.bjc.6605123

  • F Ohyanagi, N Yamamoto, A Horiike, H Harada, T Kozuka, H Murakami, K Gomi, T Takahashi, M Morota, T Nishimura, M Endo, Y Nakamura, A Tsuya, T Horai and M Nishio

    Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer

    doi:10.1038/sj.bjc.6605152

  • I P M Tomlinson, M Dunlop, H Campbell, B Zanke, S Gallinger, T Hudson, T Koessler, P D Pharoah, I Niittymäkix, S Tuupanenx, L A Aaltonen, K Hemminki, A Lindblom, A Försti, O Sieber, L Lipton, T van Wezel, H Morreau, J T Wijnen, P Devilee, K Matsuda, Y Nakamura, S Castellví-Bel, C Ruiz-Ponte, A Castells, A Carracedo, J W C Ho, P Sham, R M W Hofstra, P Vodicka, H Brenner, J Hampe, C Schafmayer, J Tepel, S Schreiber, H Völzke, M M Lerch, C A Schmidt, S Buch, V Moreno, C M Villanueva, P Peterlongo, P Radice, M M Echeverry, A Velez, L Carvajal-Carmona, R Scott, S Penegar, P Broderick, A Tenesa and R S Houlston

    COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer

    advance online publication, 2009-11-17 00:00:00.000;

    doi:10.1038/sj.bjc.6605338

  • N Yokota, S Koizume, E Miyagi, F Hirahara, Y Nakamura, K Kikuchi, W Ruf, Y Sakuma, E Tsuchiya and Y Miyagi

    Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells

    advance online publication, 2009-11-10 00:00:00.000;

    doi:10.1038/sj.bjc.6605406

  • T Yoshikawa, K Suzuki, O Kobayashi, M Sairenji, H Motohashi, A Tsuburaya, Y Nakamura, A Shimizu, S Yanoma and Y Noguchi

    Thymidine phosphorylase/platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancer

    doi:10.1038/sj.bjc.6690182

  • G Nawa, Y Miyoshi, H Yoshikawa, T Ochi and Y Nakamura

    Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours

    doi:10.1038/sj.bjc.6690484

  • C Sakakura, A Hagiwara, H Taniguchi, T Yamaguchi, H Yamagishi, T Takahashi, K Koyama, Y Nakamura, T Abe and J Inazawa

    Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization

    doi:10.1038/sj.bjc.6690638

  • Y Yasuda, T Musha, H Tanaka, Y Fujita, H Fujita, H Utsumi, T Matsuo, S Masuda, M Nagao, R Sasaki and Y Nakamura

    Inhibition of erythropoietin signalling destroys xenografts of ovarian and uterine cancers in nude mice

    doi:10.1054/bjoc.2000.1666

  • C Sakakura, A Hagiwara, R Yasuoka, Y Fujita, M Nakanishi, K Masuda, K Shimomura, Y Nakamura, J Inazawa, T Abe and H Yamagishi

    Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation

    doi:10.1054/bjoc.2000.1684